Inhibition of Thiamine Diphosphate-Dependent Enzymes by Triazole-Based Thiamine Analogues

Alex H.Y. Chan, Terence C.S. Ho, Imam Fathoni, Rebecca Pope, Kevin J. Saliba, Finian J. Leeper*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    8 Citations (Scopus)

    Abstract

    Thiamine is metabolized into the coenzyme thiamine diphosphate (ThDP). Interrupting thiamine utilization leads to disease states. Oxythiamine, a thiamine analogue, is metabolized into oxythiamine diphosphate (OxThDP), which inhibits ThDP-dependent enzymes. Oxythiamine has been used to validate thiamine utilization as an anti-malarial drug target. However, high oxythiamine doses are needed in vivo because of its rapid clearance, and its potency decreases dramatically with thiamine levels. We report herein cell-permeable thiamine analogues possessing a triazole ring and a hydroxamate tail replacing the thiazolium ring and diphosphate groups of ThDP. We characterize their broad-spectrum competitive inhibition of ThDP-dependent enzymes and of Plasmodium falciparum proliferation. We demonstrate how the cellular thiamine-utilization pathway can be probed by using our compounds and oxythiamine in parallel.

    Original languageEnglish
    Pages (from-to)621-628
    Number of pages8
    JournalACS Medicinal Chemistry Letters
    Volume14
    Issue number5
    DOIs
    Publication statusPublished - 11 May 2023

    Fingerprint

    Dive into the research topics of 'Inhibition of Thiamine Diphosphate-Dependent Enzymes by Triazole-Based Thiamine Analogues'. Together they form a unique fingerprint.

    Cite this